retatrutide eli lilly phase 2 results just announced striking 3 for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Lilly's triple agonist achieves 16.8%

The Saxenda Spin-Off: Another Weight Management Star While Ozempic and Wegovy have garnered much attention, let's not forget another GLP-1 receptor agonist family member that's been turning heads in the weight management world for years now: Saxenda (liraglutide)

the other switches it off

In addition to weight loss, Wegovy is FDA-approved to reduce the risk of major adverse cardiovascular events like heart attack and stroke in obese or overweight adults with heart disease

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses

Eventually, the FDA approved GLP-1 drugs specifically for it, Dr

How GLP-1 Medications Work GLP-1 (glucagon-like peptide-1) receptor agonists are drugs that work similarly to a naturally occurring hormone in your body responsible for regulating glucose levels and satiety